RE: Commencement of dosing23 Oct 2017 09:38
Agreed solid company.......Check out Hutchison Meditech (HCM). T/O is 216m dollars. Loss is 47m dollars. Valuation is 2.75 billion dollars! Share price is up 1000% in five years and was up barely at all in the five years prior to that.
Now look at AGY. T/O is �65m. (85m dollars) losses are �2m and valuation is �0.25 billion. Share price is 20% lower than it was 10years ago!
Whereas HCM is developing sexy anti cancer drugs for a relatively small number of people, AGY is addressing allergies which are much more common......and are more common in developed richer countries. More countries are becoming richer......and allergy prone. Around 75% of AGY shares are owned by investment companies such as Odey and Black Rock (40% of them by Abbott Labs). Why?
AGY wants to get into the US . Abbott labs has recently put one of its directors on the board of AGY. Why? Likely to oil the wheels don't you think?
In the background there's their new vaccination tech (micro crystalline tyrosine adjuvant.....along with "virus like particles") which has already proven itself an improvement for influenza vaccines and is applicable to other vaccines including Malaria which AGY are involved in. My hunch is that AGY shares could produce a high flying vapour trail like HCM! Give it 3 years maybe. At least a trebling is my guess.